Canaccord Genuity Downgrades Franco-Nevada to Hold, Announces C$200 Price Target
Canaccord Genuity analyst Carey Macrury downgrades Franco-Nevada (TSX:FNV) from Buy to Hold and announces C$200 price target.
Morgan Stanley Downgrades TELUS to Equal-Weight, Announces C$29 Price Target
Morgan Stanley analyst Simon Flannery downgrades TELUS (TSX:T) from Overweight to Equal-Weight and announces C$29 price target.
Truist Downgrades SciPlay To Hold; Reduced Price Target Implies 6% Upside
Truist analyst Matthew Thornton downgraded SciPlay Corp (NASDAQ:SCPL) to Hold from Buy with a price target of $18, down from $20,…
B of A Securities Downgrades Dow to Underperform, Lowers Price Target to $68
B of A Securities analyst Steve Byrne downgrades Dow (NYSE:DOW) from Neutral to Underperform and lowers the price target from $71 to $68.
B of A Securities Downgrades LyondellBasell Industries to Neutral, Lowers Price Target to $114
B of A Securities analyst Steve Byrne downgrades LyondellBasell Industries (NYSE:LYB) from Buy to Neutral and lowers the price target from $117 to $114.
B of A Securities Downgrades FibroGen to Neutral, Announces $29 Price Target
B of A Securities analyst Jason Gerberry downgrades FibroGen (NASDAQ:FGEN) from Buy to Neutral and announces $29 price target.
BMO Capital Downgrades Domtar to Market Perform, Raises Price Target to $55.5
BMO Capital analyst Mark Wilde downgrades Domtar (NYSE:UFS) from Outperform to Market Perform and raises the price target from $53 to $55.5.
Stifel Downgrades FibroGen to Hold, Lowers Price Target to $29
Stifel analyst Annabel Samimy downgrades FibroGen (NASDAQ:FGEN) from Buy to Hold and lowers the price target from $55 to $29.
Truist Securities Downgrades SciPlay to Hold, Lowers Price Target to $18
Truist Securities analyst Matthew Thornton downgrades SciPlay (NASDAQ:SCPL) from Buy to Hold and lowers the price target from $20 to $18.
Raymond James Downgrades Home BancShares to Market Perform
Raymond James analyst Michael Rose downgrades Home BancShares (NASDAQ:HOMB) from Outperform to Market Perform.